On Tuesday, Milestone Pharmaceuticals Inc (NASDAQ: MIST) opened lower -7.00% from the last session, before settling in for the closing price of $2.00. Price fluctuations for MIST have ranged from $1.12 to $3.52 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -29.33% over the last five years. Company’s average yearly earnings per share was noted 54.82% at the time writing. With a float of $50.58 million, this company’s outstanding shares have now reached $53.33 million.
The firm has a total of 47 workers. Let’s measure their productivity. In terms of profitability, gross margin is 167.51%, operating margin of 5034.09%, and the pretax margin is 4943.42%.
Milestone Pharmaceuticals Inc (MIST) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Milestone Pharmaceuticals Inc is 5.15%, while institutional ownership is 49.68%.
Milestone Pharmaceuticals Inc (MIST) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.32 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.32) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 54.82% per share during the next fiscal year.
Milestone Pharmaceuticals Inc (NASDAQ: MIST) Trading Performance Indicators
Check out the current performance indicators for Milestone Pharmaceuticals Inc (MIST). In the past quarter, the stock posted a quick ratio of 15.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.90, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.94 in one year’s time.
Technical Analysis of Milestone Pharmaceuticals Inc (MIST)
Analysing the last 5-days average volume posted by the [Milestone Pharmaceuticals Inc, MIST], we can find that recorded value of 0.57 million was better than the volume posted last year of 0.24 million. As of the previous 9 days, the stock’s Stochastic %D was 64.13%. Additionally, its Average True Range was 0.13.
During the past 100 days, Milestone Pharmaceuticals Inc’s (MIST) raw stochastic average was set at 65.59%, which indicates a significant increase from 39.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.19% in the past 14 days, which was higher than the 46.38% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.63, while its 200-day Moving Average is $1.57. Now, the first resistance to watch is $1.98. This is followed by the second major resistance level at $2.11. The third major resistance level sits at $2.19. If the price goes on to break the first support level at $1.78, it is likely to go to the next support level at $1.70. Should the price break the second support level, the third support level stands at $1.57.
Milestone Pharmaceuticals Inc (NASDAQ: MIST) Key Stats
There are currently 53,328K shares outstanding in the company with a market cap of 99.19 million. Presently, the company’s annual sales total 1,000 K according to its annual income of -59,690 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -9,440 K.
